Document Detail


Effects of polymyxin B-immobilized fiber using a rat cecal ligation and perforation model.
MedLine Citation:
PMID:  19357500     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We evaluated the efficacy of polymyxin B-immobilized fiber (PMX-F) on organ dysfunction using a rat cecal ligation and perforation (CLP) model. Fifteen-week-old Sprague-Dawley rats (n = 21) were divided into three groups. For a PMX group, n = 7, peritonitis was induced by CLP. After 24 hours from CLP, endotoxin adsorption was performed for 1 hour with a PMX-F column. A sham group, n = 7, external circulation was performed with nonimmobilized fiber column. A control group, n = 7, were sacrificed 25 hours after CLP (no hemoperfusion performed). The changes in interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-alpha and plasminogen activator inhibitor (PAI)-1 were measured. The lungs, liver, and kidneys were stained with hematoxylin and eosin and anti-PAI-1 antibodies. Terminal uridine-triphosphate nick-end labeling assay was performed to evaluate apoptosis. The PMX group showed a tendency to decrease in blood levels of IL-6 and PAI-1 compared with the sham group. Anti-PAI-1 antibody staining was seen in the lungs of the control and sham groups. The PMX group showed significantly decreased apoptotic cells in renal tubule cells compared with sham and control groups. We conclude that PMX-F may have inhibited PAI-1 expression in the lungs and decreased apoptosis of renal tubule cells.
Authors:
Masaaki Ito; Hajime Kase; Osamu Shimoyama; Tomonori Takahashi
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  ASAIO journal (American Society for Artificial Internal Organs : 1992)     Volume:  55     ISSN:  1538-943X     ISO Abbreviation:  ASAIO J.     Publication Date:    2009 May-Jun
Date Detail:
Created Date:  2009-05-11     Completed Date:  2009-07-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204109     Medline TA:  ASAIO J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  246-50     Citation Subset:  IM    
Affiliation:
Department of General and Gastrointestinal Surgery, Omori Hospital, Toho University School of Medicine, Tokyo, Japan. m.itoh@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Bacterial Agents / therapeutic use*
Apoptosis / physiology
Cecum / injuries,  pathology
Endotoxins / blood
Enzyme-Linked Immunosorbent Assay
Hemoperfusion / instrumentation*
Immunohistochemistry
In Situ Nick-End Labeling
Interleukin-10 / blood
Interleukin-6 / blood
Intestinal Perforation / complications
Ligation
Male
Peritonitis / etiology,  therapy*
Plasminogen Activator Inhibitor 1 / metabolism
Polymyxin B / therapeutic use*
Rats
Rats, Sprague-Dawley
Tumor Necrosis Factor-alpha / blood
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Endotoxins; 0/Interleukin-6; 0/Plasminogen Activator Inhibitor 1; 0/Tumor Necrosis Factor-alpha; 130068-27-8/Interleukin-10; 1404-26-8/Polymyxin B

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Techniques and complications of TandemHeart ventricular assist device insertion during cardiac proce...
Next Document:  Spectrum of factor IX gene mutations causing haemophilia B from India.